Ageing grey horses are particularly susceptible to melanoma. Using segregat
ion analysis, six genetic and nongeneric (environmental) models in two grey
horse family groups (n = 71) were compared. The polygenic model still fits
the data significantly better than an environmental model, indicating a st
rong genetic impact on the phenomenon. Pmel17/gp100 and TYRP1/gp75, two gen
es which are specific for melanocytes, and Cdkn2a/p16 a gene coding tor an
inhibitor of a cell cycle regulator were partially cloned, sequenced and ma
pped. Using Northern blotting analysis a striking difference in mRNA expres
sion of Pmel17/gp100 and TYRP1/gp75 was found comparing skin samples of sol
id-coloured (normal level) and grey horses (low level) as well as horse mel
anoma tumour samples thigh). Staining of skin samples with antibodies recog
nizing the product of Pmel17/gp100, confirmed the results of the correspond
ing Northern blotting analysis. It seems that Pmel17/gp100 and TYRP1/gp75 a
re involved in progressive greying of horses. No mutation was found in a pa
rtial sequence of equine Cdkn2a/p16 analysed so far. Thus, the relation bet
ween equine melanoma susceptibility and Cdkn2a/p16 is subject to further in
vestigation.